Brief: Akoustis Reports Record Revenue For Third Quarter Fiscal 2022 On 25% Sequential Growth
02/05/2022 12:50
May 2 (Reuters) - Akoustis Technologies Inc AKTS.O :
* AKOUSTIS REPORTS RECORD REVENUE FOR THIRD QUARTER FISCAL
2022 ON
25% SEQUENTIAL GROWTH
* Q3 REVENUE $4.6 MILLION
* QTRLY LOSS PER SHARE $0.27
* Q3 EARNINGS PER SHARE VIEW $-0.22, REVENUE VIEW $4.7
MILLION --
REFINITIV IBES DATA
Source text for Eikon: ID:nGNX3PTKky
Further company coverage: AKTS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aktis Oncology
See all newsAktis Oncology Q2 net loss widens on higher R&D, administrative costs
U.S. RESEARCH ROUNDUP-Danaher, GM, MSCI
Aktis Oncology Q1 net loss widens on increased IPO-related expenses
Generate Biomedicines shares fall 6% in weak Nasdaq debut for drug developer (updated)
Flagship-backed Generate Biomedicines shares fall 6% in Nasdaq debut